Skip to main content
. 2018 Dec 11;91(24):e2233–e2237. doi: 10.1212/WNL.0000000000006648

Table.

Human leukocyte antigen (HLA) class I and II haplotypes of alemtuzumab-treated vitiligo patients

graphic file with name NEUROLOGY2018904664TT1.jpg